两种猪繁殖与呼吸综合征病毒1型和2型改良活病毒疫苗同时接种对猪的效力与安全性
研究比较了分别接种PRRSV-1或PRRSV-2改良活病毒疫苗(MLV)与同时接种两种疫苗的猪只反应,并在攻毒后评估效力。四组4周龄SPF猪中,同时接种组与单独接种组的保护效果相当;PRRSV-2疫苗接种对PRRSV-2攻毒后血清病毒载量有明显降低,但对PRRSV-1攻毒效果有限;所有疫苗均未降低剖检时肺脏病毒载量。结论认为同时接种是PRRSV两型均存在猪群的一种选择,但商业疫苗仅提供部分异源攻毒保护。
要点
- 同时接种PRRSV-1和PRRSV-2 MLV疫苗的反应与单独接种相当。
- PRRSV-2疫苗接种对PRRSV-2攻毒后血清病毒载量有明显降低,对PRRSV-1攻毒效果有限。
- 所有疫苗均未降低剖检时肺脏病毒载量,商业疫苗仅部分保护异源攻毒。
核心结论
- 同时接种含PRRSV-1和PRRSV-2的MLV疫苗所引发的反应与单独接种相当,商业PRRSV疫苗对异源毒株攻毒仅提供部分保护。
- 因此,在同时存在两种PRRSV类型的猪群中,同时接种两种疫苗是一种选择。
研究设计与样本
- 实验设计包括四组4周龄SPF猪;第0天(DPV0),第1-3组(每组N=18)分别接种含PRRSV-1病毒(VAC-T1)、PRRSV-2病毒(VAC-T2)或两者(VAC-T1T2)的改良活病毒疫苗(MLV),一组未接种(N=12)。
- DPV 62,第1-4组猪只混合分组并以PRRSV-1亚型1、PRRSV-1亚型2或PRRSV-2攻毒(DPC 0)。
- DPC 13/14所有猪只剖检,接种和攻毒后采集样本。
主要发现
- 所有接种猪中均检测到PRRSV,多数猪直到DPV 28呈阳性,但少数猪在接种后62天仍有病毒血症。
- 鼻拭子在直到DPV 7-14检测到病毒。
- 攻毒后未观察到明显临床症状。
- PRRSV-2疫苗接种对PRRSV-2攻毒后血清病毒载量有明显降低,而对PRRSV-1毒株攻毒后血清病毒载量影响有限。
- 针对PRRSV-1的疫苗接种对攻毒后病毒血症影响较小;同时接种PRRSV 1型和2型MLV疫苗与单独接种PRRS MLV疫苗的保护效果相当。
临床怎么用
- 在同时存在两种PRRSV类型的猪群中,同时接种两种疫苗是一种选择。
局限性
- 商业PRRSV疫苗对异源毒株攻毒仅提供部分保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of the study was to compare responses of pigs vaccinated with a PRRS MLV vaccine against PRRSV-1 or PRRSV-2 with the responses of pigs vaccinated simultaneously with both vaccines. Furthermore, the efficacy of the two PRRSV MLV vaccination strategies was assessed following challenge. The experimental design included four groups of 4-weeks old SPF-pigs. On day 0 (DPV0), groups 1-3 (N=18 per group) were vaccinated with modified live virus vaccines (MLV) containing PRRSV-1 virus (VAC-T1), PRRSV-2 virus (VAC-T2) or both (VAC-T1T2). One group was left unvaccinated (N=12). On DPV 62, the pigs from groups 1-4 were mingled in new groups and challenged (DPC 0) with PRRSV-1, subtype 1, PRRSV-1, subtype 2 or PRRSV-2. On DPC 13/14 all pigs were necropsied. Samples were collected after vaccination and challenge. PRRSV was detected in all vaccinated pigs and the majority of the pigs were positive until DPV 28, but few of the pigs were still viremic 62 days after vaccination. Virus was detected in nasal swabs until DPV 7-14. No overt clinical signs were observed after challenge. PRRSV-2 vaccination resulted in a clear reduction in viral load in serum after PRRSV-2 challenge, whereas there was limited effect on the viral load in serum following challenge with the PRRSV-1 strains. Vaccination against PRRSV-1 had less impact on viremia following challenge. The protective effects of simultaneous vaccination with PRRSV Type 1 and 2 MLV vaccines and single PRRS MLV vaccination were comparable. None of the vaccines decreased the viral load in the lungs at necropsy. In conclusion, simultaneous vaccination with MLV vaccines containing PRRSV-1 and PRRSV-2 elicited responses comparable to single vaccination and the commercial PRRSV vaccines protected only partially against challenge with heterologous strains. Thus, simultaneous administration of the two vaccines is an option in herds with both PRRSV types.
引用
- Kristensen CS, Kvisgaard LK, Pawlowski M, et al. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs. Vaccine. 2017. PMID: 29191738. doi:10.1016/j.vaccine.2017.11.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。